HomeCompareTLGT vs BTI

TLGT vs BTI: Dividend Comparison 2026

TLGT yields 27377.52% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TLGT wins by $1.188659204665963e+21M in total portfolio value
10 years
TLGT
TLGT
● Live price
27377.52%
Share price
$0.17
Annual div
$47.50
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.188659204665963e+21M
Annual income
$1,180,179,287,020,189,700,000,000,000.00
Full TLGT calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — TLGT vs BTI

📍 TLGT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTLGTBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TLGT + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TLGT pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TLGT
Annual income on $10K today (after 15% tax)
$2,327,089.34/yr
After 10yr DRIP, annual income (after tax)
$1,003,152,393,967,161,200,000,000,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, TLGT beats the other by $1,003,152,393,967,161,200,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TLGT + BTI for your $10,000?

TLGT: 50%BTI: 50%
100% BTI50/50100% TLGT
Portfolio after 10yr
$594329602332981460992.00M
Annual income
$590,089,643,510,094,850,000,000,000.00/yr
Blended yield
99.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

TLGT
Analyst Ratings
1
Buy
3
Hold
Consensus: Hold
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TLGT buys
0
BTI buys
0
No recent congressional trades found for TLGT or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTLGTBTI
Forward yield27377.52%5.38%
Annual dividend / share$47.50$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$1.188659204665963e+21M$37.7K
Annual income after 10y$1,180,179,287,020,189,700,000,000,000.00$2,786.64
Total dividends collected$1.188100965028857e+21M$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy

Year-by-year: TLGT vs BTI ($10,000, DRIP)

YearTLGT PortfolioTLGT Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$2,748,452$2,737,752.16$11,299$598.92+$2.74MTLGT
2$706,172,699$703,231,854.70$12,794$703.91+$706.16MTLGT
3$169,619,770,362$168,864,165,574.45$14,518$829.07+$169619.76MTLGT
4$38,088,480,331,187$37,906,987,176,899.56$16,513$978.64+$38088480.31MTLGT
5$7,995,983,294,959,344$7,955,228,621,004,974.00$18,827$1,157.84+$7995983294.94MTLGT
6$1,569,355,212,688,684,500$1,560,799,510,563,078,100.00$21,518$1,373.12+$1569355212688.66MTLGT
7$287,973,521,392,263,700,000$286,294,311,314,686,770,000.00$24,657$1,632.46+$287973521392263.69MTLGT
8$49,405,729,451,981,220,000,000$49,097,597,784,091,490,000,000.00$28,329$1,945.74+$49405729451981216.00MTLGT
9$7,925,156,678,292,761,000,000,000$7,872,292,547,779,143,000,000,000.00$32,637$2,325.33+$7925156678292761600.00MTLGT
10$1,188,659,204,665,962,900,000,000,000$1,180,179,287,020,189,700,000,000,000.00$37,708$2,786.64+$1.188659204665963e+21MTLGT

TLGT vs BTI: Complete Analysis 2026

TLGTStock

Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.

Full TLGT Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this TLGT vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TLGT vs SCHDTLGT vs JEPITLGT vs OTLGT vs KOTLGT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.